ConferenceJ Thorac Oncol · June 1, 2026
INTRODUCTION: Machine learning algorithms may improve the efficiency and accuracy of pathologic response (PR) assessment in surgically resected lung cancers after neoadjuvant therapy. The aim of this study was to develop digital models for quantifying tumo ...
Full textLink to itemCite
ConferenceFrontiers in Cardiovascular Medicine · January 1, 2025
Ex vivo machine perfusion has been growing in utility for preserving donor organs prior to transplantation. This modality has tremendous potential for bioengineering and conditioning organs prior to transplantation using small molecule or advanced therapeu ...
Full textCite
ConferenceCirculation · November 12, 2024
Introduction:
Sarcoidosis is a granulomatous disease of unknown cause that can affect any organ. Cardiac involvement, indicated by arrhythmias, conduction abnormalities, heart failure, and sudden card ...
Full textCite
ConferenceJournal of Clinical Oncology · June 1, 2023
2588 Background: Immunotherapies, including immune checkpoint inhibitors (ICI), have revolutionized the treatment of many cancers, producing significant improvements in survival in patients with many different cancers. However, t ...
Full textCite
ConferenceCirculation · November 8, 2022
Introduction:
Use of gene therapy for cardiac transplantation is limited by the lack of an effective recombinant Adeno-associated viral vector (rAAV) gene delivery strategy.
E ...
Full textCite
ConferenceIEEE International Conference on Computational Photography Iccp 2022 · January 1, 2022
We report Tensorial Tomographic Differential Phase-Contrast microscopy (T2DPC), a quantitative label-free tomographic imaging method for simultaneous measurement of phase and anisotropy. T2DPC extends differential phase-contrast microscopy, a quantitative ...
Full textCite
ConferenceThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · April 1, 2020
PURPOSE: Cardiac transplant patients must be on lifelong surveillance for the occurrence of acute cellular rejection (ACR). Despite potent immunosuppressants, ACR occurs when recipient T cells recognize donor antigens to cause cardiac myocyte destruction. ...
Full textCite
ConferenceThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · April 1, 2020
PURPOSE: Acute cellular rejection (ACR), and its relation to chronic lung allograft dysfunction (CLAD), is an important cause of morbidity and mortality in lung transplant patients. ACR occurs in more than one third of lung transplant recipients in the fir ...
Full textCite